ArticleFrontiers in pharmacology2022

Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT-IKK/STAT3 Axis.

Xiaoping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.